VEGF Gene Delivery for Treatment of Ischemic Cardiovascular Disease
- 1 April 2002
- journal article
- research article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 12 (3) , 108-114
- https://doi.org/10.1016/s1050-1738(01)00158-x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsPublished by Elsevier ,2004
- Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneNature, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.Journal of Clinical Investigation, 1994
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.Journal of Clinical Investigation, 1989
- Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth FactorScience, 1984
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971
- ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESISThe Journal of Experimental Medicine, 1971